Drug search by name

NovaLog Mix 50/50 and Renal/liver disease

Result of checking the interaction of drug NovaLog Mix 50/50 and disease Renal/liver disease for safety when used together.

Check result:

NovaLog Mix 50/50 <> Renal/liver disease

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Insulin requirements may be diminished in patients with renal or hepatic impairment due to reduced insulin metabolism and, in the latter case, also to reduced capacity for gluconeogenesis. Lower initial dosages may be appropriate, with careful monitoring of plasma glucose levels and dosing adjustments.

References:

"Product Information. Novolog (insulin aspart)" Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
"Product Information. Humulin BR (insulin)." Lilly, Eli and Company, Indianapolis, IN.
"Product Information. Lantus (insulin glargine)" Aventis Pharmaceuticals, Swiftwater, PA.

NovaLog Mix 50/50

Generic Name: insulin aspart / insulin aspart protamine

Brand Name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill

Synonyms: Insulin aspart and insulin aspart protamine, Insulin Aspart Protamine and Insulin Aspart

What is NovaLog Mix 50/50?